3 ফলাফল
This application is a 35 U.S.C. 371 national stage filing and claims priority to PCT Application No. PCT/IN2014/000201, entitled "Novel Chromone Alkaloid Dysoline for the Treatment of Cancer and Inflammatory Disorders" filed on Mar. 31, 2014, which claims priority to Indian Application No.
FIELD OF INVENTION
This invention relates to certain chemical compounds and their use as valuable pharmaceutical agents, particularly as lipoxygenase inhibitors and/or leukotriene antagonists possessing anti-inflammatory and anti-allergic properties.
SUMMARY OF THE INVENTION
This invention relates
FIELD OF THE INVENTION
This invention relates to chromone derivatives which inhibit matrix metalloproteinase enzymes and thus are useful for treating diseases resulting from MMP-mediated tissue breakdown such as heart disease, cardiac insufficiency, inflammatory bowel disease, multiple sclerosis,